Efficacy and Safety of Letrozole and Abemaciclib in ER-Positive Recurrent Endometrial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer
J. Clin. Oncol 2022 Sep 29;[EPub Ahead of Print], PA Konstantinopoulos, EK Lee, N Xiong, C Krasner, S Campos, DL Kolin, JF Liu, N Horowitz, AA Wright, S Bouberhan, RT Penson, O Yeku, B Bowes, H Needham, M Hayes, H Sawyer, M Polak, M Shea, SC Cheng, C Castro, UA MatulonisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.